chr7-105457785-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_019042.5(PUS7):c.*5T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000429 in 1,613,780 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0024 ( 5 hom., cov: 32)
Exomes 𝑓: 0.00023 ( 2 hom. )
Consequence
PUS7
NM_019042.5 3_prime_UTR
NM_019042.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.167
Genes affected
PUS7 (HGNC:26033): (pseudouridine synthase 7) Enables enzyme binding activity and pseudouridine synthase activity. Involved in several processes, including pseudouridine synthesis; regulation of hematopoietic stem cell differentiation; and regulation of mesoderm development. Located in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 7-105457785-A-G is Benign according to our data. Variant chr7-105457785-A-G is described in ClinVar as [Benign]. Clinvar id is 3037449.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00236 (359/152378) while in subpopulation AFR AF= 0.00825 (343/41600). AF 95% confidence interval is 0.00753. There are 5 homozygotes in gnomad4. There are 168 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PUS7 | NM_019042.5 | c.*5T>C | 3_prime_UTR_variant | 16/16 | ENST00000469408.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PUS7 | ENST00000469408.6 | c.*5T>C | 3_prime_UTR_variant | 16/16 | 1 | NM_019042.5 | P1 | ||
PUS7 | ENST00000356362.6 | c.*5T>C | 3_prime_UTR_variant | 16/16 | 2 | P1 | |||
PUS7 | ENST00000481939.5 | c.*643+1383T>C | intron_variant, NMD_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00236 AC: 359AN: 152260Hom.: 5 Cov.: 32
GnomAD3 genomes
AF:
AC:
359
AN:
152260
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000645 AC: 162AN: 251112Hom.: 1 AF XY: 0.000494 AC XY: 67AN XY: 135726
GnomAD3 exomes
AF:
AC:
162
AN:
251112
Hom.:
AF XY:
AC XY:
67
AN XY:
135726
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000229 AC: 334AN: 1461402Hom.: 2 Cov.: 30 AF XY: 0.000183 AC XY: 133AN XY: 726978
GnomAD4 exome
AF:
AC:
334
AN:
1461402
Hom.:
Cov.:
30
AF XY:
AC XY:
133
AN XY:
726978
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00236 AC: 359AN: 152378Hom.: 5 Cov.: 32 AF XY: 0.00225 AC XY: 168AN XY: 74518
GnomAD4 genome
AF:
AC:
359
AN:
152378
Hom.:
Cov.:
32
AF XY:
AC XY:
168
AN XY:
74518
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PUS7-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 31, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at